Traders sold shares of UnitedHealth Group Inc. (NYSE:UNH) on strength during trading hours on Wednesday. $76.90 million flowed into the stock on the tick-up and $118.58 million flowed out of the stock on the tick-down, for a money net flow of $41.68 million out of the stock. Of all companies tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $2.44 for the day and closed at $139.91

UNH has been the topic of several recent analyst reports. Mizuho boosted their target price on UnitedHealth Group from $156.00 to $160.00 and gave the stock a “buy” rating in a research report on Tuesday, July 19th. Credit Suisse Group AG restated a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a report on Wednesday, June 29th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Citigroup Inc. upped their price target on UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $154.96.

The company’s 50-day moving average is $138.90 and its 200-day moving average is $135.14. The company has a market cap of $133.25 billion, a P/E ratio of 21.90 and a beta of 0.57.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/traders-sell-shares-of-unitedhealth-group-inc-unh-on-strength-unh.html

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The firm had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. On average, equities research analysts anticipate that UnitedHealth Group Inc. will post $7.92 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were given a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.79%. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.65% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Emerald Acquisition Ltd. acquired a new position in UnitedHealth Group during the second quarter valued at about $309,266,000. Bank of Montreal Can acquired a new position in UnitedHealth Group during the second quarter valued at about $207,013,000. Dodge & Cox raised its position in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares during the period. Boston Partners raised its position in UnitedHealth Group by 47.6% in the second quarter. Boston Partners now owns 3,531,669 shares of the healthcare conglomerate’s stock valued at $498,672,000 after buying an additional 1,138,808 shares during the period. Finally, Vanguard Group Inc. raised its position in UnitedHealth Group by 2.0% in the second quarter. Vanguard Group Inc. now owns 57,213,923 shares of the healthcare conglomerate’s stock valued at $8,078,605,000 after buying an additional 1,123,084 shares during the period. Hedge funds and other institutional investors own 85.78% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.